Dermatology Medical News about psoriasis vulgaris

Dermatology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Dermatology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Dermatology

Autoimmune/Bullous Dz

Basic Science/Genetics

Clinical Pharmacology

Cosmetic Derm/Acne

Derm Allergy/Immunology

Derm Infectious Disease

Dermatologic Oncology

Dermatologic Surgery

Dermatopathology

Economics of Medicine

Laser Surgery

Pediatric Dermatology

Photodermatology

Popular Press

Psoriasis

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

The Best of 2008
D Scott Cunningham MD, PhD, MDLinx

Technology Advances: #17. New Antibody Takes a BiTE at Melanoma
Dorothy J. Schirf, MD, MDLinx Oncology

See all

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series
BMC Dermatology, 09/17/07

Email This Article

Save in My Library

Free Full Text

Lowes, M.A., et al. - Newer biological therapies for moderate-to-severe psoriasis are being used more frequently, but unexpected effects may occur...Conclusion: We hypothesize that these papules may represent a unique type of "mechanistic" inflammatory reaction, seen only in the context of drug-induced CD11a blockade, and not during the natural disease process

Dermatology Articles: Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance